Handover period group | Non-handover period group | P-value | |
---|---|---|---|
Baseline characteristics | |||
Cases | 40(17.3%) | 191(82.6%) | |
Gender | 40 | 191 | 0.676 |
Male | 30 | 137 | |
Female | 10 | 54 | |
Age | 62.4 (± 2.48) | 62.8 (± 4.32) | 0.358 |
BMI | 28.92 (± 2.09) | 28.75 (± 2.38) | 0.684 |
Current smoking | 20 (± 0.50) | 104 (± 0.49) | 0.610 |
Dyslipidemia | 30 (± 0.43) | 155 (± 0.39) | 0.378 |
Diabetes mellitus | 18 (± 0.50) | 58 (± 0.46) | 0.096 |
Heart failure history | 7 (± 0.38) | 26 (± 0.34) | 0.525 |
Renal failure history | 4 (± 0.30) | 23 (± 0.32) | 0.716 |
Previous myocardial infarction | 5 (± 0.33) | 16 (± 0.27) | 0.412 |
Killip class(arrival) | 0.781 | ||
I | 27 | 115 | |
II | 6 | 59 | |
III | 5 | 12 | |
IV | 2 | 5 | |
Nursing efficiency | |||
D2FMC (minutes) | 2.92 (± 0.72) | 2.8 (± 0.76) | 0.589 |
FMC2FE (minutes) | 2.12 (± 0.56) | 2.14 (± 0.61) | 0.876 |
FMC2BS (minutes) | 9.92 (± 2.60) | 7.84 (± 2.36) | 0.000** |
BS2CBR (minutes) | 13. (± 0.64) | 12.91 (± 0.77) | 0.004* |
FMC2FAD (minutes) | 8.10 (± 0.95) | 6.95 (± 1.14) | 0.000** |
D2W (minutes) | 70.6 (± 2.02) | 69.21 (± 2.34) | 0.001* |
Outcomes | |||
Occurrence of major adverse cardiovascular events | 6 | 29 | 0.977 |
Highest troponin values within 72 h of hospitalization(TNT, ng/L) | 2542 (± 2206.21) | 2252.4 (± 2424.93) | 0.486 |
Hospitalization (days) | 13.8 (± 2.13) | 13.39 (± 2.45) | 0.337 |